Transplantation Market Size, Share & Trends Report

Transplantation Market Size, Share & Trends Analysis Report By Product Type (Tissue Products, Immunosuppressive Drugs), By Application Type (Organ, Tissue Transplants), By End Use, And Segment Forecasts, 2020 - 2027

  • Published Date: Jun, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-1-68038-864-0
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global transplantation market size was estimated at USD 12.8 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2020 to 2027. Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to market growth. Organ failure usually occurs due to various factors, such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases.

U.S. transplantation market size

Demand for tissue and organ transplantation, mainly, kidney, heart, liver, and lungs, is very high. Unhealthy dietary habits, alcohol consumption, lack of exercise, and drug abuse are some of the leading causes of organ failure. Thus, demand for transplantation products is expected to rise in the near future. Rising incidences of acute diseases have also resulted in increased cases of organ failures.

For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, where kidney transplant or dialysis are the only treatment options to keep a patient alive. According to the U.S. Department of Health & Human Services, in 2019, there were around 122,913 patients in U.S. with the requirement of organ transplants. Thus, the high demand for advanced transplantation products will drive market growth. In addition, the introduction of technologically advanced products and an increasing number of tissue banks are likely to boost the market growth.

However, lack of awareness regarding organ donation and religious & customary beliefs prevents a large number of people from donation. Thus, the shortage of organs for the treatment of organ failure is expected to adversely affect market growth. There is a huge gap between demand and supply of organs for organ failure treatment. According to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients with kidney transplant requirements in U.S.; however, only 23,401 kidney transplant procedures were performed.

Product Type Insights

Tissue products were the highest revenue-generating segment in 2019 and accounted for a share of 57.9%. Major products used for tissue or organ transplantation are tissue products, immunosuppressants, and preservation solutions. The increasing number of transplantation procedures, such as cochlear, heart valves, bone marrow, and orthopedic soft tissues, is driving the segment growth. In addition, new product development is fueling segment growth. For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, a new orthobiologic product intended for use in capsular reconstruction. This product allows retention of its growth factors and native collagen scaffold and elastin and allows transplant to be successfully incorporated into the receiver.

Manufacturers are focusing on new product development, mergers & acquisition, and collaborations to expand their current product portfolio and strengthen the market position. For instance, in September 2016, Stryker Corporation announced the acquisition of Instratek, a leading manufacturer of minimally invasive soft tissue recession instruments for the ankle, foot, and upper extremity procedures.

Immunosuppressive drugs segment is projected to showcase the fastest growth during the forecast period. This can be attributed to the high usage of these drugs to prevent post-transplant tissue or organ rejection. The increasing prevalence of chronic diseases has led to a rise in demand for organ replacement globally. Thus, the demand for immunosuppressive drugs is expected to rise at a significant pace.

The preservation solutions segment is expected to exhibit significant growth during the study period due to rising government support for stem cell research and wide application scope for these products to improve the physiological function of organs. In addition, an increasing number of organ donations and organ transplant procedures are expected to drive the segment growth.

Application Type Insights

Tissue transplantation led the market in 2019 accounting for a share of over 60% and will expand further at the fastest CAGR from 2020 to 2027. This is due to the fact that replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are the most commonly performed procedures worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products.

The organ transplantation segment is expected to grow at a significant growth rate of 8.6% during the forecast period. Increasing number of organ transplant procedures as well as repetitive purchase of immunosuppressants are anticipated to boost the segment growth. For instance, in 2017, around 90,306 kidney transplant procedures were performed globally.

Germany transplantation market share

Advancement in transplantation technology and the launch of new products are expected to propel the number of transplant procedures, including kidney, liver, heart, lungs, and tissues. For instance, in September 2015, Arthrex, Inc. announced the launch of ArthroFlex Acellular Dermal Matrix, which provides high strength and support to restore stability in capsular reconstruction.

In 2019, high number of transplant procedures were documented in U.S., Germany, U.K., and France, and this number is expected to increase in the near future. Well-developed healthcare infrastructure and availability of expert surgeons & advanced products in these countries are some key factors that can be attributed to market growth of the regional market. Thus, the high demand for transplantation products will drive the market.

End-use Insights

Hospitals segment held the largest market share of over 49% in 2019 and will retain its dominant position during the forecast period owing to the rising number of organ and tissue transplant procedures performed at hospitals as they are primary treatment centers. In addition, the emergence of hospitals with developed infrastructure is expected to fuel market growth.

The transplant centers segment is expected to register the highest growth rate over the forecast period. The rising number of transplantation procedures has triggered the need for an increased number of healthcare centers catering to the unmet needs of the patients. Also, rising government initiatives to encourage organ donation is projected to propel the market growth. For instance, the Health Resources and Services Administration's Division of Transplantation sponsored four grant programs.

As a result of established healthcare infrastructure in U.S., France, U.K., and other European countries, the demand for advanced transplant products for the management of organ failure & tissue replacement has increased. Moreover, the number of advanced transplant centers in these regions is increasing. According to the National Kidney Center, there are around 244 kidney transplant centers in U.S.

Moreover, a rising number of organ donors and improving healthcare infrastructure in developing economies, such as China, India, Argentina, and Brazil, are expected to propel segment growth. In addition, demand for these products in these countries is rising due to the growing burden of acute and chronic diseases, such as high blood pressure and diabetes.

Regional Insights

North America led the market with a share of 40.1% in 2019 and is expected to maintain its dominance throughout the study period. Well-developed healthcare facilities and the presence of many major biotechnologies and medical devices manufacturing companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker, are supporting the market growth.

The gap between demand and supply of organs, including kidney, liver, and heart, for transplantation has increased in the last decade. However, governments and NGOs of various countries are taking initiatives to encourage people to donate organs and save lives. New guidelines and rules for organ donation make the donation process more transparent and easier. In 2020, the Human Resource & Services Administration launched the Hospital Organ Donor Campaign in April 2020. This led to an increased number of organ donations from the previous year.

Asia Pacific market is projected to register the fastest CAGR during the forecast period, owing to the growing research on stem cells to develop in vitro tissue and organs. In addition, developing healthcare infrastructure in several Asian countries, such as India, Thailand, Philippines, and Indonesia, is projected to drive the regional market.

Key Companies and Market share Insights

The market is highly fragmented with the presence of many large, small, and medium-scale vendors. Major market participants focus more on new product launch, mergers & acquisitions, and regional expansions to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, in June 2015, Zimmer Holdings, Inc. announced the acquisition of Biomet to strengthen its product portfolio and distribution channels.

Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting, have led to high demand for transplant products. The 3D bioprinting can be used to regenerate tissues and organs. For instance, Organovo Holdings, Inc., a 3D biology company, announced in January 2014 that it completed its first 3D Liver tissue delivery.  Some of the prominent players in the global transplantation market include:

Some of the prominent players in the industry include:

  • Abbvie, Inc.

  • Arthrex, Inc.

  • Zimmer Biomet

  • Medtronic PLC

  • Novartis AG

  • Strykers

  • 21st Century Medicine

  • BiolifeSolutions, Inc.

  • Teva Pharmaceuticals

  • Veloxis Pharmaceutical

Transplantation Market Report Scope

Report Attribute

Details

Market size value in 2020

USD 13.8 Billion

Revenue forecast in 2027

USD 25.8 Billion

Growth Rate

CAGR of 9.3% from 2020 to 2027

Base year for estimation

2019

Historical data

2016 - 2019

Forecast period

2020 - 2027

Quantitative units

Revenue in USD billion and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product,  application, end use, region

Regional scope

North America, Europe, Asia Pacific, Latin America, and MEA

Country scope

U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, Brazil, Mexico, South Africa, and Saudi Arabia,

Key companies profiled

AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic PLC; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each sub-segment from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global transplantation market report on the basis of product type, application type, end use, and region:

  • Product Type Outlook (Revenue, USD Billion, 2016 - 2027)

    • Tissue products

    • Immunosuppressive drugs

    • Preservation solution

  • Application Type Outlook (Revenue, USD Billion, 2016 - 2027)

    • Organ transplantation

    • Tissue transplantation

  • End-use Outlook (Revenue, USD Billion, 2016 - 2027)

    • Hospitals

    • Transplant centers

    • Others

  • Regional Outlook (Revenue, USD Billion, 2016 - 2027)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Quality assurance

    Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Information security

    Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • grand view research PCI DSS complaint grand view research gdpr verified
  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities